DK443988A - Injektionspraeparat indeholdende modificeret tpa - Google Patents
Injektionspraeparat indeholdende modificeret tpaInfo
- Publication number
- DK443988A DK443988A DK443988A DK443988A DK443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A DK 443988 A DK443988 A DK 443988A
- Authority
- DK
- Denmark
- Prior art keywords
- preparation containing
- containing modified
- injection preparation
- modified tpa
- tpa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/49—Urokinase; Tissue plasminogen activator
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62199381A JP2708749B2 (ja) | 1987-08-10 | 1987-08-10 | 修飾型tPA含有注射用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
DK443988D0 DK443988D0 (da) | 1988-08-09 |
DK443988A true DK443988A (da) | 1989-02-11 |
Family
ID=16406817
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK443988A DK443988A (da) | 1987-08-10 | 1988-08-09 | Injektionspraeparat indeholdende modificeret tpa |
Country Status (11)
Country | Link |
---|---|
US (1) | US5425943A (no) |
EP (1) | EP0303251B1 (no) |
JP (1) | JP2708749B2 (no) |
KR (1) | KR910009366B1 (no) |
AT (1) | ATE84220T1 (no) |
CA (1) | CA1338699C (no) |
DE (1) | DE3877277T2 (no) |
DK (1) | DK443988A (no) |
ES (1) | ES2052651T3 (no) |
GR (1) | GR3006748T3 (no) |
NO (1) | NO178325C (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453363A (en) * | 1985-10-23 | 1995-09-26 | Boehringer Mannheim Gmbh | Process for the activation of t-PA or Ing after genetic expression in prokaryotes |
US4980165A (en) * | 1989-01-27 | 1990-12-25 | Genetics Institute, Inc. | Pharmaceutical formulations of plasminogen activator proteins |
JP2520975B2 (ja) * | 1989-09-21 | 1996-07-31 | 三井東圧化学株式会社 | 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤 |
DE3939346A1 (de) * | 1989-11-29 | 1991-06-06 | Behringwerke Ag | Arzneimitel zur subkutanen oder intramuskulaeren applikation enthaltend polypeptide |
US6372716B1 (en) * | 1994-04-26 | 2002-04-16 | Genetics Institute, Inc. | Formulations for factor IX |
US5770700A (en) * | 1996-01-25 | 1998-06-23 | Genetics Institute, Inc. | Liquid factor IX formulations |
TWI240627B (en) * | 1996-04-26 | 2005-10-01 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
EP0827751B1 (en) * | 1996-09-06 | 2003-02-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Medicinal composition containing tissue plasminogen activator and nicotinamide |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54147916A (en) * | 1978-05-12 | 1979-11-19 | Sumitomo Chem Co Ltd | Preparation of urokinase injection |
WO1984001786A1 (en) * | 1982-10-28 | 1984-05-10 | Beecham Group Plc | Enzyme derivatives and their use in the treatment of thrombosis |
GB8334498D0 (en) * | 1983-12-24 | 1984-02-01 | Beecham Group Plc | Compounds |
JPS60184026A (ja) * | 1984-03-01 | 1985-09-19 | Asahi Chem Ind Co Ltd | 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助方法 |
EP0156169B1 (en) * | 1984-02-29 | 1991-12-18 | Asahi Kasei Kogyo Kabushiki Kaisha | An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method |
JPS60181028A (ja) * | 1984-02-29 | 1985-09-14 | Asahi Chem Ind Co Ltd | 組織プラスミノ−ゲン・アクチベ−タ−の溶解補助法 |
GB8503358D0 (en) * | 1985-02-09 | 1985-03-13 | Beecham Group Plc | Compounds |
GB8508717D0 (en) * | 1985-04-03 | 1985-05-09 | Beecham Group Plc | Composition |
DE3682104D1 (de) * | 1985-04-22 | 1991-11-28 | Genentech Inc | Plasminogenaktivator-mutante des menschlichen gewebes, verfahren und zwischenprodukte dafuer und diese mutante verwendende zusammensetzungen. |
US4916071A (en) * | 1985-08-14 | 1990-04-10 | American Home Products Corporation | Poly-kringle plasminogen activator |
NZ217331A (en) * | 1985-08-26 | 1989-05-29 | Lilly Co Eli | Tissue plasminogen activator derivatives and genetically engineered product |
US4960702A (en) * | 1985-09-06 | 1990-10-02 | Codon | Methods for recovery of tissue plasminogen activator |
JPH0811066B2 (ja) * | 1985-09-30 | 1996-02-07 | インテグレーテッド・ジエネティックス・インコーポレーテッド | 組換えdnaが生産するヒト子宮プラスミノ−ゲンアクチベ−タ− |
JPH0672105B2 (ja) * | 1985-10-02 | 1994-09-14 | 持田製薬株式会社 | 血栓溶解剤及びその製法 |
JPS62120321A (ja) * | 1985-11-20 | 1987-06-01 | Eisai Co Ltd | tPA含有医薬組成物 |
US4777043A (en) | 1985-12-17 | 1988-10-11 | Genentech, Inc. | Stabilized human tissue plasminogen activator compositions |
EP0227462B1 (en) * | 1985-12-23 | 1992-04-01 | Chiron Corporation | Novel peptide plasminogen activators |
US4935237A (en) * | 1988-03-21 | 1990-06-19 | Genentech, Inc. | Processes for the preparation of t-PA mutants |
US4898826A (en) * | 1987-12-10 | 1990-02-06 | Invitron Corporation | Method to solubilize tissue plasminogen activator |
-
1987
- 1987-08-10 JP JP62199381A patent/JP2708749B2/ja not_active Expired - Lifetime
-
1988
- 1988-07-27 KR KR1019880009479A patent/KR910009366B1/ko not_active IP Right Cessation
- 1988-08-08 NO NO883520A patent/NO178325C/no not_active IP Right Cessation
- 1988-08-09 DK DK443988A patent/DK443988A/da not_active Application Discontinuation
- 1988-08-10 ES ES88113000T patent/ES2052651T3/es not_active Expired - Lifetime
- 1988-08-10 CA CA000574367A patent/CA1338699C/en not_active Expired - Fee Related
- 1988-08-10 AT AT88113000T patent/ATE84220T1/de not_active IP Right Cessation
- 1988-08-10 EP EP88113000A patent/EP0303251B1/en not_active Revoked
- 1988-08-10 DE DE8888113000T patent/DE3877277T2/de not_active Revoked
-
1992
- 1992-06-22 US US07/900,796 patent/US5425943A/en not_active Expired - Lifetime
-
1993
- 1993-01-08 GR GR920402266T patent/GR3006748T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
ATE84220T1 (de) | 1993-01-15 |
DE3877277D1 (de) | 1993-02-18 |
EP0303251A2 (en) | 1989-02-15 |
NO178325B (no) | 1995-11-27 |
NO178325C (no) | 1996-03-06 |
GR3006748T3 (no) | 1993-06-30 |
EP0303251B1 (en) | 1993-01-07 |
NO883520D0 (no) | 1988-08-08 |
JPS6442442A (en) | 1989-02-14 |
ES2052651T3 (es) | 1994-07-16 |
JP2708749B2 (ja) | 1998-02-04 |
US5425943A (en) | 1995-06-20 |
KR910009366B1 (ko) | 1991-11-14 |
KR890003404A (ko) | 1989-04-14 |
EP0303251A3 (en) | 1990-01-31 |
NO883520L (no) | 1989-02-13 |
DK443988D0 (da) | 1988-08-09 |
DE3877277T2 (de) | 1993-06-03 |
CA1338699C (en) | 1996-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI901421A0 (fi) | N-(3-hydroxi-4-piperidinyl) (dihydrobenzofuran, dihydro-2h-benzopyran- eller dihydrobenzodioxin) karboxiamidderivat. | |
DK24389A (da) | (cycloalkylamino)methylenbis(phosphonsyre) og farmaceutiske praeparater indeholdende forbindelsen | |
DK524187D0 (da) | Aminosyrechelaterede midler til udlevering til specifikke biologiske vaevssteder | |
SE8603582L (sv) | Komposition innehallande l-dopa | |
DE68922405D1 (de) | Deletionsanaloga von magaininpeptiden. | |
IT1187828B (it) | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi | |
SE8404065D0 (sv) | Novel biologically active compounds | |
DK443988D0 (da) | Injektionspraeparat indeholdende modificeret tpa | |
PT86233A (fr) | Procede de preparation d:une variant de l:hirudine | |
ATE65401T1 (de) | Stabile, injizierbare loesungen von salzen von vincristin. | |
FI863078A (fi) | Kontinuerligt frigoerande peptidkompositioner. | |
BG88028A (bg) | Амиди на циклометилен-1,2-дикарбоксилни киселини с терапевтична активност,методи за получаването им и фармацевтични състави, които ги съдържат | |
ATE92315T1 (de) | Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate. | |
PT93991A (pt) | Processo para a preparacao de solucoes estaveis de analogos de rebecamicina | |
BG90414A (bg) | 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им | |
HU896173D0 (no) | ||
IT8621828A0 (it) | Oftalmiche. sale di lisina dell'acido 4-bifenilacetico e sue composizioni | |
ATE10845T1 (de) | Verfahren zur herstellung von n-(4-(((2,4-diamino-6-pteridinyl)methyl)methyla ino)benzoyl)- glutaminsaeure. | |
DE68900693D1 (de) | Pharmazeutische praeparate zur transdermalen applikation von heparin. | |
DE3578172D1 (de) | 2,5-pyrrolidindion-derivate mit antiarrhythmischer wirkung. | |
IT8621283A0 (it) | Sale di lisina dell'acido 4-bifenilacetico e sue compositioni oftalmiche. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHS | Application shelved for other reasons than non-payment |